Patents by Inventor Michiaki Tominaga
Michiaki Tominaga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5985869Abstract: Novel benzoheterocyclic compounds of the formula: ##STR1## wherein R.sup.1 is H, halogen, alkyl, optionally substituted amino, alkoxy; R.sup.2 is H, halogen, alkoxy, phenylalkoxy, OH, alkyl, optionally substituted amino, carbamoyl-alkoxy, optionally substituted amino-alkoxy, optionally substituted benzoyloxy; R.sup.3 is a group: --NR.sup.4 R.sup.5 or --CO--NR.sup.11 R.sup.12 ; R.sup.4 is H, optionally substitued benzoyl, alkyl; R.sup.5 is a group: ##STR2## [R.sup.16 is halogen, optionally substituted alkyl, OH, alkoxy, alkanoyloxy, alkylthio, alkanoyl, carboxy, alkoxycarbonyl, CN, NO.sub.2, optionally substituted amino, phenyl, cycloalkyl, etc., or a group: --O--A--NR.sup.6 R.sup.7 ; m is 0 to 3], phenyl-alkoxycarbonyl, alkanoyl, phenylalkanoyl, etc.; R.sup.11 is H or alkyl; R.sup.12 is cycloalkyl or optionally substituted phenyl; and W is a group: --(CH.sub.2).sub.p (p is 3 to 5) or --CH.dbd.CH--(CH.sub.2).sub.q (q is 1 to 3), the carbon atom of these groups beign optionally replaced by O, S, SO, SO.sub.Type: GrantFiled: July 15, 1997Date of Patent: November 16, 1999Assignee: Otsuka Pharmaceutical Company, LimitedInventors: Hidenori Ogawa, Hisashi Miyamoto, Kazumi Kondo, Hiroshi Yamashita, Kenji Nakaya, Hajime Komatsu, Michinori Tanaka, Shinya Kora, Michiaki Tominaga, Yoichi Yabuuchi
-
Patent number: 5925640Abstract: An object of the invention is to provide an apoptosis regulating composition. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient, at least one carbostyril derivatives of general formula (1) and salts thereof.Type: GrantFiled: May 9, 1997Date of Patent: July 20, 1999Assignee: Otsuka Pharmaceutical Co. Ltd.Inventors: Satoru Nakai, Koutoku Aihara, Hitomi Mori, Michiaki Tominaga, Masakazu Adachi, Hiroyuki Ichikawa, Seiji Akamatsu, Fumio Saito
-
Patent number: 5916890Abstract: An object of the invention is to provide an apoptosis regulating composition. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient, at least one carbostyril derivatives of general formula (1) ##STR1## and salts thereof.Type: GrantFiled: May 9, 1997Date of Patent: June 29, 1999Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoru Nakai, Koutoku Aihara, Hitomi Mori, Michiaki Tominaga, Masakazu Adachi, Hiroyuki Ichikawa, Seiji Akamatsu, Fumio Saito
-
Patent number: 5886010Abstract: A method for the prophylaxis and treatment of diseases induced by accelerated INF-.alpha. secretion, such as rheumatoid arthritis, endotoxin shock, adult respiratory distress syndrome, thermal burn, asthma, myocardial infarction, acute phase of viral myocardiosis, etc. which comprises administering a carbostyril compound of the formula: ##STR1## wherein R.sup.1 is H or lower alkyl, and R.sup.2 is phenyl(lower)alkyl having optionally 1 to 3 lower alkoxy substituents on the phenyl ring, or a pharmaceutically acceptable salt thereof to a subject.Type: GrantFiled: July 3, 1997Date of Patent: March 23, 1999Assignee: Otsuka Pharmaceutical Company, LimitedInventors: Toyoki Mori, Michiaki Tominaga, Yukihisa Ono
-
Patent number: 5872120Abstract: An object of the invention is to provide an apoptosis regulating composition. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient, at least one carbostyril derivatives of general formula (1) ##STR1## and salts thereof.Type: GrantFiled: May 9, 1997Date of Patent: February 16, 1999Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoru Nakai, Koutoku Aihara, Hitomi Mori, Michiaki Tominaga, Masakazu Adachi, Hiroyuki Ichikawa, Seiji Akamatsu, Fumio Saito
-
Patent number: 5827862Abstract: An agent for prophylaxis or treatment of cataract, which comprises as an active ingredient at least one compound selected from a group consisting of a carbostyril compound of the formula: ##STR1## wherein R.sup.1 is a lower alkanoylamino-substituted lower alkoxy group, and the bond between the 3- and 4-positions of the carbostyril nucleus is single bond or double bond, or a salt thereof, 5-dimethylamino-1-?4-(2-methylbenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H- benzazepine and 5-hydroxy-7-chloro-1-?2-methyl-4-(2-methylbenzoylamino)benzoyl!-2,3,4,5-te trahydro-1H-benzazepine, a method for prophylaxis or treatment of cataract using the same.Type: GrantFiled: August 23, 1995Date of Patent: October 27, 1998Assignee: Otsuka Pharmaceutical Company, LimitedInventors: Yoshitaka Yamamura, Tatsuya Yamashita, Shigeki Nakamura, Toshiyuki Onogawa, Yoshihisa Yamada, Kenji Tsujimae, Hidenorii Ogawa, Toyoki Mori, Michiaki Tominaga
-
Patent number: 5798358Abstract: An object of the invention is to provide an apoptosis regulating composition. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient, at least one carbostyril derivatives of general formula (1) ##STR1## and salts thereof.Type: GrantFiled: May 9, 1997Date of Patent: August 25, 1998Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoru Nakai, Koutoku Aihara, Hitomi Mori, Michiaki Tominaga, Masakazu Adachi, Hiroyuki Ichikawa, Seiji Akamatsu, Fumio Saito
-
Patent number: 5760058Abstract: Peripheral vasodilating agents containing as an active ingredient, a piperidine derivative or pharmaceutically acceptable salt thereof having excellent peripheral vasodilating activity, said piperidine derivative or pharmaceutically acceptable salt thereof being represented by the general formula (1) ##STR1## wherein R, R.sup.1 and R.sup.2 are as defined herein.Type: GrantFiled: February 3, 1997Date of Patent: June 2, 1998Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Takafumi Fujioka, Shuji Teramoto, Michinori Tanaka, Hiroshi Shimizu, Fujio Tabusa, Michiaki Tominaga
-
Patent number: 5753644Abstract: An object of the present invention is to provide a vasopressin antagonist and oxytocin antagonist.The vasopressing antagonist and oxytocin antagonist according to the present invention contain, as the active ingredient, a benzoheterocyclic compound represented by the general formula (1): ##STR1## (wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and the carbon-carbon bond between 4- and 5-positions in the benzoazepine skeleton are the same as defined in claims 1, 2 and 3.) or salt thereof.Type: GrantFiled: October 15, 1996Date of Patent: May 19, 1998Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Hidenori Ogawa, Kazumi Kondo, Hiroshi Yamashita, Kenji Nakaya, Hajime Komatsu, Michinori Tanaka, Kazuyoshi Kitano, Michiaki Tominaga, Yoichi Yabuuchi
-
Patent number: 5753677Abstract: Novel benzoheterocyclic compounds of the formula: ##STR1## which have excellent vasopressin antagonistic activities and are useful as vasodilator, hypotensive agent, water diuretics, platelet agglutination inhibitor, and a vasopressin antagonistic composition containing the compound as the active ingredient.Type: GrantFiled: June 7, 1995Date of Patent: May 19, 1998Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Hidenori Ogawa, Hisashi Miyamoto, Kazumi Kondo, Hiroshi Yamashita, Kenji Nakaya, Hajime Komatsu, Michinori Tanaka, Shinya Kora, Michiaki Tominaga, Yoichi Yabuuchi
-
Patent number: 5750529Abstract: An object of the invention is to provide an apoptosis regulating composition. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient, at least one carbostyril derivatives of general formula (1) ##STR1## and salts thereof.Type: GrantFiled: June 6, 1995Date of Patent: May 12, 1998Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoru Nakai, Koutoku Aihara, Hitomi Mori, Michiaki Tominaga, Masakazu Adachi, Hiroyuki Ichikawa, Seiji Akamatsu, Fumio Saito
-
Patent number: 5691341Abstract: Apoptosis regulating compositions each comprising a member selected from a series of carbostyril derivatives and salts thereof, inclusive of carbostyril derivatives of general formula (1) ##STR1## and salts thereof, as an active ingredient are provided. The apoptosis regulating compositions of the invention are of use as anticancer agents, antiretrovirus agents, therapeutic agents for autoimmune diseases, therapeutic agents for thrombocytopenia, therapeutic agents for Alzheimer's disease, therapeutic agents for diseases of the liver, and cancer metastasis inhibitors, among others.Type: GrantFiled: August 29, 1995Date of Patent: November 25, 1997Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoru Nakai, Koutoku Aihara, Hideo Tanaka, Hitomi Iba, Kazuyoshi Kawai, Hiroyuki Ichikawa, Seiji Akamatsu, Fumio Saito, Michiaki Tominaga, Masakazu Adachi
-
Patent number: 5677319Abstract: A superoxide radical inhibitor containing, as an effective ingredient, an azole derivative represented by the general formula (1), ##STR1## ?wherein R.sup.1 represents a phenyl group which may have 1-3 lower alkoxy groups as substituent(s) on the phenyl ring, a phenyl group having a lower alkylenedioxy group, or the like; R.sup.2 represents a hydrogen atom, a phenyl group, a halogen atom, a lower alkoxycarbonyl group, a lower alkyl group, an amino-lower alkyl group which may have a lower alkyl group as a substituent, a dihydrocarbostyril group, or the like; R.sup.3 represents a group of the formula, ##STR2## (R.sup.4B represents a hydroxyl group, a carboxy group, a lower alkenyl group or a lower alkyl group. m represents 0, 1 or 2); X represents a sulfur atom or an oxygen atom! or a salt thereof.Type: GrantFiled: June 7, 1995Date of Patent: October 14, 1997Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Masatoshi Chihiro, Hajime Komatsu, Michiaki Tominaga, Yoichi Yabuuchi
-
Patent number: 5677299Abstract: Novel benzoheterocyclic compound of the formula (1): ##STR1## and pharmaceutically acceptable salts thereof, which show excellent anti-vasopressin activity and oxytocin antagonistic activity, and are useful as a vasopressin antagonist or oxytocin antagonist.Type: GrantFiled: June 6, 1995Date of Patent: October 14, 1997Assignee: Otsuka Pharmaceutical Company, LimitedInventors: Hidenori Ogawa, Kazumi Kondo, Hiroshi Yamashita, Keizo Kan, Michiaki Tominaga, Yoichi Yabuuchi
-
Patent number: 5672603Abstract: An object of the invention is to provide an apoptosis regulating composition. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient at least one carbostyril derivatives of general formula (1) ##STR1## and salts thereof.Type: GrantFiled: June 6, 1995Date of Patent: September 30, 1997Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoru Nakai, Koutoku Aihara, Hitomi Mori, Michiaki Tominaga, Masakazu Adachi, Hiroyuki Ichikawa, Seiji Akamatsu, Fumio Saito
-
Patent number: 5658912Abstract: An object of the invention is to provide an apoptosis regulating composition. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient, at least one carbostyril derivatives of general formula (1) ##STR1## and salts thereof.Type: GrantFiled: June 6, 1995Date of Patent: August 19, 1997Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoru Nakai, Koutoku Aihara, Hitomi Mori, Michiaki Tominaga, Masakazu Adachi, Hiroyuki Ichikawa, Seiji Akamatsu, Fumio Saito
-
Patent number: 5656642Abstract: The present invention relates to novel peripheral vasodilating agents characterized by each containing as an active ingredient, a piperidine derivative or pharmaceutically acceptable salt thereof having excellent peripheral vasodilating activity.Said piperidine derivative or pharmaceutically acceptable salt thereof is represented by the general formula (1): ##STR1## (wherein R, R.sup.1 and R.sup.2 are the same as defined above.Type: GrantFiled: December 6, 1994Date of Patent: August 12, 1997Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Takafumi Fujioka, Shuji Teramoto, Michinori Tanaka, Hiroshi Shimizu, Fujio Tabusa, Michiaki Tominaga
-
Patent number: 5654317Abstract: An antiarrhythmic agent which comprises as an active ingredient a carbostyril derivative of the formula: ##STR1## wherein R.sub.1 is hydrogen atom or a lower alkyl group, and R.sub.2 is a phenyl-lower alkyl group which has optionally 1 to 3 substituents of a lower alkoxy group on the phenyl ring, or a pharmaceutically acceptable salt thereof.Type: GrantFiled: March 17, 1995Date of Patent: August 5, 1997Assignee: Otsuka Pharmaceutical Company, LimitedInventors: Takafumi Fujioka, Shuji Teramoto, Michiaki Tominaga, Yoichi Yabuuchi
-
Patent number: 5652247Abstract: Novel carbostyril derivatives of the formula: ##STR1## wherein R.sup.1 is H, NO.sub.2, alkoxy, alkoxycarbonyl, alkyl, halogen, optionally substituted amino, OH, CN, COOH, alkanoyloxy, hydrazinocarbonyl; q is 1 to 3, and R is a group of the formula: ##STR2## [wherein R.sup.2 is H, alkoxycarbonyl, optionally substituted phenoxycarbonyl, phenylalkenyl-CO--, optionally substituted phenylalkanoyl, alkanoyl, alkenyl-CO--, optionally substituted phenyl-SO.sub.2 --, --CONR.sup.8 R.sup.9, optionally substituted heterocyclic group-CO--, naphthyl-CO--, thienylalkanoyl, tricyclo[3.3.1.1]alkanoyl, ##STR3## (R.sup.13 is OH, optionally substituted alkoxy, --NR.sup.32 R.sup.33, --O--A--(E).sub.l --NR.sup.4 R.sup.5, --(B).sub.l --NR.sup.6 R.sup.7, etc.),n is 1 or 2, m is 0 or 1 to 3, R.sup.3 is alkyl, R.sup.10 is --(CO).sub.l --NR.sup.11 R.sup.Type: GrantFiled: December 14, 1994Date of Patent: July 29, 1997Assignee: Otsuka Pharmaceutical Co., LtdInventors: Hidenori Ogawa, Hisashi Miyamoto, Kazumi Kondo, Hiroshi Yamashita, Kenji Nakaya, Michiaki Tominaga, Yoichi Yabuuchi
-
Patent number: 5643932Abstract: A superoxide radical inhibitor containing, as an effective ingredient, an azole derivative represented by the general formula (1), ##STR1## [wherein R.sup.1 represents a phenyl group which may have 1-3 lower alkoxy groups as substituent(s) on the phenyl ring, a phenyl group having a lower alkylenedioxy group, or the like; R.sup.2 represents a hydrogen atom, a phenyl group, a halogen atom, a lower alkoxycarbonyl group, a lower alkyl group, an amino-lower alkyl group which may have a lower alkyl group as a substituent, a dihydrocarbostyril group, or the like; R.sup.3 represents a group of the formula, ##STR2## (R.sup.4B represents a hydroxyl group, a carboxy group, a lower alkenyl group or a lower alkyl group. m represents 0, 1 or 2); X represents a sulfur atom or an oxygen atom] or a salt thereof.Type: GrantFiled: May 19, 1995Date of Patent: July 1, 1997Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Masatoshi Chihiro, Hajime Komatsu, Michiaki Tominaga, Yoichi Yabuuchi